Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DU PRINTEMPS : revenue, balance sheet and financial ratios

PHARMACIE DU PRINTEMPS is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SARTROUVILLE (78500), this company of category PME shows in 2025 a net income positive of 206 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DU PRINTEMPS (SIREN 834077232)
Indicator 2025 2024 2023 2020 2019 2018
Revenue N/C N/C N/C N/C N/C N/C
Net income 205 561 € 359 721 € -167 336 € 219 554 € 213 319 € 53 911 €
EBITDA N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, PHARMACIE DU PRINTEMPS generates positive net income of 206 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 54 k€ -> 206 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

205 561 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 612%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

612.182%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

12.489%

Solvency indicators evolution
PHARMACIE DU PRINTEMPS

Sector positioning

Debt ratio
612.18 2025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Watch +50 pts over 3 years

In 2025, the debt ratio of PHARMACIE DU PRINTEMPS (612.18) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
12.49% 2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Watch

In 2025, the financial autonomy of PHARMACIE DU PRINTEMPS (12.5%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Positioning of PHARMACIE DU PRINTEMPS in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE DU PRINTEMPS is estimated at 3 265 360 € (range 2 215 889€ - 5 123 800€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
2215k€ 3265k€ 5123k€
3 265 360 € Range: 2 215 889€ - 5 123 800€
NAF 5 année 2025

Valuation method used

Net Income Multiple
205 561 € × 15.9x = 3 265 361 €
Range: 2 215 889€ - 5 123 801€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DU PRINTEMPS with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DU PRINTEMPS

What is the revenue of PHARMACIE DU PRINTEMPS ?

The revenue of PHARMACIE DU PRINTEMPS is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE DU PRINTEMPS profitable?

Yes, PHARMACIE DU PRINTEMPS generated a net profit of 206 k€ in 2025.

Where is the headquarters of PHARMACIE DU PRINTEMPS ?

The headquarters of PHARMACIE DU PRINTEMPS is located in SARTROUVILLE (78500), in the department Yvelines.

Where to find the tax return of PHARMACIE DU PRINTEMPS ?

The tax return of PHARMACIE DU PRINTEMPS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DU PRINTEMPS operate?

PHARMACIE DU PRINTEMPS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.